We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Biden Administration Delays Rule to Lower Out-of-Pocket Costs for 340B Drugs
Biden Administration Delays Rule to Lower Out-of-Pocket Costs for 340B Drugs
The Biden administration has delayed an HHS rule that would have stopped community health centers from getting federal funds unless they charged low-income patients reduced out-of-pocket prices for insulin and injectable epinephrine.